Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1079 of 6351
-
Can herbal medicine and hormones prevent miscarriage? major trial reveals results
Disease control CompletedThreatened miscarriage is manifested by vaginal bleeding, with or without abdominal pain, while the cervix is closed and the fetus is viable and inside the uterine cavity. Threatened miscarriage is a common complication of pregnancy occurring in 20% of all clinically recognized p…
Phase 3 • Sponsor: Heilongjiang University of Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Promising trial aims to spare throat cancer patients from unnecessary radiation
Disease control Recruiting nowThis is a phase II clinical trial. The purpose of this study is to determine the feasibility of deescalating chemoradiation treatment based on mid-treatment tumor response determined by rapid nodal shrinkage and clearance of circulating HPV plasma tumor DNA . The primary objectiv…
Phase 2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New drug cocktail shows promise for tough stomach cancer
Disease control CompletedFruquintinib once daily in 4 weeks treatment cycle (three weeks on and one week off) in combination with Paclitaxel 80mg/㎡(day1, 8, 15 of 4 weeks cycle) was well tolerated and demonstrated encouraging preliminary clinical antitumor activity in patients with advanced GC in ph1b/2 …
Phase 3 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Can a simple steroid help babies recover faster from heart surgery?
Disease control CompletedThis study's objective is to determine the pharmacokinetics (PK)/pharmacodynamics (PD), safety and efficacy of methylprednisolone in infants undergoing heart surgery with cardiopulmonary bypass. This is a prospective, double blind, multi-center, placebo-controlled safety and effi…
Phase 3 • Sponsor: Kevin Hill • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could less radiation be just as effective for HPV throat cancer?
Disease control OngoingThe purpose of this study is to demonstrate that participants with HPV positive and hypoxia negative T1-2, N1-2c (AJCC, 7th ed.) oropharyngeal squamous cell carcinoma receiving a major de-escalated radiation therapy with 2 cycles of standard chemotherapy is not inferior to compar…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for rare eye cancer: IMCgp100 shows promise in advanced uveal melanoma trial
Disease control CompletedTo evaluate the overall survival of HLA-A\*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investigator's Choice of dacarbazine, ipilimumab, or pembrolizumab.
Phase 2 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
One-Time radiation boost during breast surgery shows promise in Early-Stage cancer trial
Disease control OngoingThis phase II trial studies the side effects of intraoperative electron beam radiotherapy boost and to see how well it works in treating patients with stage I-II breast cancer undergoing surgery with reconstruction. Giving a single dose of electron beam radiation to the tumor cav…
Phase 2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Simple cheek swab could predict sudden cardiac death risk
Diagnosis Recruiting nowEvery week in the UK, 12 apparently healthy and fit individuals under the age of 35 die suddenly, a tragic event known as sudden cardiac death (SCD). The investigators have shown that heritable cardiac disorders affect the distribution of proteins at the cardiac cell-cell junctio…
Sponsor: St. George's Hospital, London • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
New drug combos aim to boost survival in Hard-to-Treat cancers
Disease control Stopped earlyA Phase Ib/II, open label, multi-center, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of immunotherapy-based treatment combinations in patients with locally advanced unresectable or metastatic G/GEJ cancer (her…
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New enzyme therapy shows promise in controlling rare blood clotting disorder
Disease control CompletedThrombotic thrombocytopenic purpura (or TTP for short) is a condition where blood clots form in small blood vessels throughout the body. The clots can limit or block the flow of oxygen-rich blood to the body's organs, such as the brain, kidneys, and heart. As a result, serious he…
Phase 3 • Sponsor: Baxalta now part of Shire • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Smart scans guide tailored therapy for hodgkin lymphoma patients
Disease control OngoingThis phase II trial evaluates how well AVD (doxorubicin, vinblastine, dacarbazine) in combination with brentuximab vedotin and nivolumab work in treating patients with stage I-II Hodgkin lymphoma. Drugs used in the chemotherapy, such as doxorubicin, vinblastine, dacarbazine, and …
Phase 2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for Tough-to-Treat blood cancers: targeted pill shows promise
Disease control OngoingThis is a Phase 2, open-label, multicenter study, evaluating the efficacy of venetoclax in participants with relapsed or refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) either in presence of 17p deletion (Cohort 1) or those who have failed a B-recep…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Experimental bladder cancer drug shows promise but trial halted early
Disease control Stopped earlyThis study will test an experimental drug (enfortumab vedotin) alone and with different combinations of anticancer therapies. Pembrolizumab is an immune checkpoint inhibitor (CPI) that is used to treat patients with cancer of the urinary system (urothelial cancer). This type of c…
Phase 1/2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can simple exercises prevent postpartum pelvic problems?
Prevention CompletedObjective: To compare the effectiveness of pelviperineal physiotherapy hypopressive exercise, and pelvic health education for the prevention and treatment of postpartum pelvic floor dysfunction in primiparous women after vaginal delivery.
Sponsor: University of Alcala • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
Blood tests may help decide best time to switch lung cancer drugs
Disease control CompletedThe phase II APPLE trial gives the opportunity to prospectively validate liquid biopsies as a new standard for testing tumor progression compared with conventional radiological procedure in EGFR mutant advanced NSCLC patients. Moreover based on the sequential T790M test during tr…
Phase 2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a simple vitamin save lives in the ICU?
Disease control Recruiting nowIn the VITdAL-ICU trial using a large oral dose of vitamin D3 in 480 adult critically ill patients, there was no benefit regarding the primary endpoint hospital length of stay. However, the predefined subgroup with severe vitamin D deficiency (25(OH)D ≤ 12ng/ml) had significantly…
Phase 3 • Sponsor: Medical University of Graz • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could your own fat cells fight ALS? new trial tests safety and effectiveness
Disease control OngoingThe purpose of this study is to determine the safety and efficacy of intrathecal treatment delivered to the cerebrospinal fluid (CSF) of mesenchymal stem cells in ALS patients every 3 months for a total of 4 injections over 12 months. Mesenchymal stem cells (MSCs) are a type of …
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Radioactive therapy targets rare tumors in new trial
Disease control Recruiting nowBackground: Pheochromocytoma and paraganglioma are rare tumors. They usually form inside and near the adrenal gland or in the neck region. Not all these tumors can be removed with surgery, and there are no good treatments if the disease has spread. Researchers think a new drug m…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a Breath-Activated inhaler match the standard for asthma control?
Disease control CompletedPrimary Objective To demonstrate the non-inferiority of Foster® NEXThaler® 100/6 µg versus (vs.) Foster® pressurised metered dose inhaler (pMDI) 100/6 µg in terms of pulmonary function (change from baseline to the entire treatment period in average pre-dose morning peak expirato…
Phase 3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Promising combo therapy targets rare protein disease in major trial
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of daratumumab plus cyclophosphamide, bortezomib and dexamethasone (CyBorD) compared with CyBorD alone in treatment of newly diagnosed amyloid light chain (AL) amyloidosis participants.
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC